The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Genetic aberrations and survival in plasma cell leukemia
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
World Health Organization Classification of Tumours
Fletcher, C., van den Berg, A., & Molenaar, I. (2002) · Cited by 7,079
Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands.
Herman, J. G., Graff, J. R., Myöhänen, S., Nelkin, B. D., & Baylin, S. B. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.18.9821 · Cited by 5,646
Hossfeld, D. K. (2002) · Annals of Oncology · doi:10.1093/annonc/mdf146 · Cited by 4,625
Crystal Structure of a p53 Tumor Suppressor-DNA Complex: Understanding Tumorigenic Mutations
Cho, Y., Gorina, S., Jeffrey, P. D., & Pavletich, N. P. (1994) · Science · doi:10.1126/science.8023157 · Cited by 2,551
Pathology and Genetics: Tumours of Haematopoietic and Lymphoid Tissues
Jaffe, E. S. (2003) · Cited by 2,141
Stott, F. J. (1998) · The EMBO Journal · doi:10.1093/emboj/17.17.5001 · Cited by 1,167
Kato, S., Han, S.-Y., Liu, W., Otsuka, K., Shibata, H., Kanamaru, R., & Ishioka, C. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1431692100 · Cited by 874
Ganguly, A., Rock, M. J., & Prockop, D. J. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.21.10325 · Cited by 674
Twenty years of p53 research: structural and functional aspects of the p53 protein
May, P., & May, E. (1999) · Oncogene · doi:10.1038/sj.onc.1203285 · Cited by 663
Clinical and biologic implications of recurrent genomic aberrations in myeloma
Fonseca, R., Blood, E., Rue, M., Harrington, D., Oken, M. M., Kyle, R. A., Dewald, G. W., Van Ness, B., Van Wier, S. A., Henderson, K. J., et al. (2003) · Blood · doi:10.1182/blood-2002-10-3017 · Cited by 660
Self-citationChesi, M., Bergsagel, P. L., Shonukan, O. O., Martelli, M. L., Brents, L. A., Chen, T., Schröck, E., Ried, T., & Kuehl, W. M. (1998) · Blood · doi:10.1182/blood.v91.12.4457 · Cited by 401
Self-citationGertz, M. A. (2005) · Blood · doi:10.1182/blood-2005-04-1411 · Cited by 360
Self-citationGenomic abnormalities in monoclonal gammopathy of undetermined significance
Fonseca, R., Bailey, R. J., Ahmann, G. J., Rajkumar, S. V., Hoyer, J. D., Lust, J. A., Kyle, R. A., Gertz, M. A., Greipp, P. R., & Dewald, G. W. (2002) · Blood · doi:10.1182/blood.v100.4.1417.h81602001417_1417_1424 · Cited by 348
Self-citationGarcı́a-Sanz, R., Orfão, A., González, M., Tabernero, M. D., Bladé, J., Moro, M. J., Fernández-Calvo, J., Sanz, M. A., Pérez-Simón, J. A., Rasillo, A., et al. (1999) · Blood · doi:10.1182/blood.v93.3.1032 · Cited by 332
The recurrent IgH translocations are highly associated with nonhyperdiploid variant multiple myeloma
Fonseca, R., Debes-Marun, C. S., Picken, E. B., Dewald, G. W., Bryant, S. C., Winkler, J. M., Blood, E., Oken, M. M., Santana-Dávila, R., González-Paz, N., et al. (2003) · Blood · doi:10.1182/blood-2003-02-0493 · Cited by 296
Self-citationDahia, P. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.2.185 · Cited by 274
Magdinier, F., & Wolffe, A. P. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.101617298 · Cited by 197
Avet-Loiseau, H., Daviet, A., Brigaudeau, C., Callet-Bauchu, E., Terré, C., Lafage-Pochitaloff, M., Désangles, F., Ramond, S., Talmant, P., & Bataille, R. (2001) · Blood · doi:10.1182/blood.v97.3.822 · Cited by 185
Plasma cell leukemia: An evaluation of response to therapy
Noel, P., & Kyle, R. A. (1987) · The American Journal of Medicine · doi:10.1016/0002-9343(87)90942-9 · Cited by 184
Self-citationDimopoulos, M. A., Palumbo, A., Delasalle, K. B., & Alexanian, R. (1994) · British Journal of Haematology · doi:10.1111/j.1365-2141.1994.tb05114.x · Cited by 184
Fonseca, R., Harrington, D. P., Oken, M. M., Dewald, G. W., Bailey, R. J., Wier, S. A. V., Henderson, K. J., Blood, E., Rajkumar, S. V., Kay, N. E., et al. (2002) · PubMed · Cited by 180
Self-citationBezieau, S., Devilder, M.-C., Avet-Loiseau, H., Mellerin, M.-P., Puthier, D., Pennarun, E., Rapp, M.-J., Harousseau, J.-L., Moisan, J.-P., & Bataille, R. (2001) · Human Mutation · doi:10.1002/humu.1177 · Cited by 180
Clinical significance of TP53 mutation in myeloma
Chng, W. J., Price-Troska, T. L., Gonzalez-Paz, N. C., Wier, S. V., Jacobus, S. J., Blood, E., Henderson, K. J., Oken, M. M., Ness, B. V., Greipp, P. T., et al. (2007) · Leukemia · doi:10.1038/sj.leu.2404524 · Cited by 144
Self-citationThe growth fraction of human myeloma cells
Drewinko, B., Alexanian, R., Boyer, H., Barlogie, B., & Rubinow, S. (1981) · Blood · doi:10.1182/blood.v57.2.333.333 · Cited by 141
Hayman, S. R., Bailey, R. J., Jalal, S. M., Ahmann, G. J., Dispenzieri, A. A., Gertz, M. A., Greipp, P. R., Kyle, R. A., Lacy, M. Q., Rajkumar, S. V., et al. (2001) · Blood · doi:10.1182/blood.v98.7.2266 · Cited by 140
Self-citationEssential Role of AKT-1/Protein Kinase Bα in PTEN-Controlled Tumorigenesis
Stiles, B. L., Gilman, V., Khanzenzon, N., Lesche, R., Li, A., Qiao, R., Liu, X. Z., & Wu, H. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.11.3842-3851.2002 · Cited by 139
p14ARF silencing by promoter hypermethylation mediates abnormal intracellular localization of MDM2.
Esteller, M., Cordon‐Cardo, C., Corn, P. G., Meltzer, S. J., Pohar, K. S., Watkins, D. N., Capellá, G., Peinado, M. A., Matías‐Guiu, X., Prat, J., et al. (2001) · PubMed · Cited by 132
Ahuja, H., Foti, A., Bar‐Eli, M., & Cline, M. (1990) · Blood · doi:10.1182/blood.v75.8.1684.1684 · Cited by 129
Loss of PTEN expression leading to high Akt activation in human multiple myelomas
Hyun, T. S., Yam, A., Pece, S., Xie, X., Zhang, J., Miki, T., Gutkind, J. S., & Li, W. (2000) · Blood · doi:10.1182/blood.v96.10.3560 · Cited by 127
Albarracín, F., & Fonseca, R. (2011) · Blood Reviews · doi:10.1016/j.blre.2011.01.005 · Cited by 127
Self-citationEymin, B., Gazzéri, S., Brambilla, C., & Brambilla, E. M. (2002) · Oncogene · doi:10.1038/sj.onc.1205359 · Cited by 106
An update on conformation sensitive gel electrophoresis
Ganguly, A. A. (2002) · Human Mutation · doi:10.1002/humu.10059 · Cited by 100
Fonseca, R., Oken, M., & Greipp, P. (2001) · Blood · doi:10.1182/blood.v98.4.1271 · Cited by 97
Self-citationSmadja, N., Leroux, D., Soulier, J., Dumont, S., Arnould, C., Taviaux, S. A., Taillemite, J. L., & Bastard, C. (2003) · Genes Chromosomes and Cancer · doi:10.1002/gcc.10275 · Cited by 97
Liang, D., Shih, L., Fu, J., et al. (2006) · Cancer · doi:10.1002/cncr.21687 · Cited by 84
Seidl, S., Ackermann, J., Kaufmann, H., Keck, A. V., Nösslinger, T., Zielinski, C. C., Drach, J. W., & Zöchbauer‐Müller, S. (2004) · Cancer · doi:10.1002/cncr.20295 · Cited by 70
Analysis of PTEN deletions and mutations in multiple myeloma
Chang, H., Xiao, Q., Claudio, J. O., Zhuang, L., Patterson, B. J., & Stewart, A. K. (2005) · Leukemia Research · doi:10.1016/j.leukres.2005.07.008 · Cited by 69
Self-citationTargeting mutants of PTEN reveal distinct subsets of tumour suppressor functions
Leslie, N. R., Bennett, D., Alex, G. R. A. Y., et al. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3570427 · Cited by 53
Oken, M. M., Leong, T. L., Lenhard, R. E., Greipp, P. R., Kay, N. E., Ness, B. V., Keimowitz, R. M., & Kyle, R. A. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19990915)86:6<957::aid-cncr10>3.0.co;2-8 · Cited by 50
Self-citationMultiple Myeloma an update on diagnosis and management
Kyle, R. A. (1990) · Acta Oncologica · doi:10.3109/02841869009089984 · Cited by 38
Self-citationAnalysis of p73 and p53 gene deletions in multiple myeloma
Schultheis, B. S., Krämer, A., Willer, A., Hegenbart, U., Goldschmidt, H., & Hehlmann, R. (1999) · Leukemia · doi:10.1038/sj.leu.2401609 · Cited by 32
N-RASandK-RASgene mutations in Brazilian patients with multiple myeloma
Ortega, M. M., de Faria, R. M. D., Shitara, E. S., de Assis, Â. M., de Albuquerque, D. M., de Oliveira, J. S. R., Noguti, M. A. E., de Faria, J. R., Costa, F. F., & Lima, C. S. P. (2005) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190500300969 · Cited by 10
Cited by
International Myeloma Working Group molecular classification of multiple myeloma: spotlight review
Fonseca, R., Bergsagel, P. L., Drach, J., Shaughnessy, J., Gutierrez, N., Stewart, A. K., Morgan, G., Van Ness, B., Chesi, M., Minvielle, S., et al. (2009) · Leukemia · doi:10.1038/leu.2009.174 · Cited by 886
Self-citationKumar, S. K., Mikhael, J. R., Buadi, F. K., Dingli, D., Dispenzieri, A., Fonseca, R., Gertz, M. A., Greipp, P. R., Hayman, S. R., Kyle, R. A., et al. (2009) · Mayo Clinic Proceedings · doi:10.4065/mcp.2009.0603 · Cited by 628
Self-citationGenomic complexity of multiple myeloma and its clinical implications
Manier, S., Salem, K. Z., Park, J., Landau, D. A., Getz, G., & Ghobrial, I. M. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.122 · Cited by 560
Mikhael, J. R., Dingli, D., Roy, V., Reeder, C. B., Buadi, F. K., Hayman, S. R., Dispenzieri, A., Fonseca, R., Sher, T., Kyle, R. A., et al. (2013) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2013.01.019 · Cited by 500
Self-citationSpatial genomic heterogeneity in multiple myeloma revealed by multi-region sequencing
Rasche, L., Chavan, S. S., Stephens, O. W., Patel, P. H., Tytarenko, R., Ashby, C., Bauer, M., Stein, C., Deshpande, S., Wardell, C., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00296-y · Cited by 417
Metadata
- Authors
- Tiedemann, R. E., Gonzalez-Paz, N., Kyle, R. A., Santana-Davila, R., Price-Troska, T., Van Wier, S. A., Chng, W. J., Ketterling, R. P., Gertz, M. A., Henderson, K., Greipp, P. R., Dispenzieri, A., Lacy, M. Q., Rajkumar, S. V., Bergsagel, P. L., Stewart, A. K., & Fonseca, R.
- Venue
- Leukemia
- Published
- 2008-01-24
- Volume
- 22
- Issue
- 5
- Pages
- 1044-1052
- ISSN
- 0887-6924 (ISSN-L)
- 1476-5551
- OpenAlex
- W2003426156
- Cited by
- 349
- References
- 42
- FWCI
- 8.40
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.